Award

Provision of Multiple Sclerosis Management Service for Children

NHS ENGLAND - SPECIALISED COMMISSIONING

This public procurement record has 2 releases in its history.

Award

16 Oct 2023 at 13:06

Planning

22 Nov 2022 at 10:52

Summary of the contracting process

The NHS England Specialised Commissioning has awarded contracts for the provision of Multiple Sclerosis Management Services for Children across three regions in England - the North, Midlands, and London and the South. The total contract value for all three Lots is £5,784,145. The contract was signed on 10th March 2023, with a three-year anticipated period. The service is highly specialised and involves expert management of paediatric patients with demyelinating conditions.

This tender presents lucrative opportunities for paediatric providers with expertise in neuroinflammatory conditions and experience in managing paediatric demyelinating syndromes. The incumbent providers for each Lot have been awarded contracts through a limited procurement process due to the absence of competition. Prospective providers were invited to participate in a market engagement exercise to inform future commissioning plans. The tender aims to ensure continuity and high-quality care for paediatric MS patients across different regions in England.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Provision of Multiple Sclerosis Management Service for Children

Notice Description

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.

Lot Information

Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,

This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.

Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England

This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.

Lot 3 - London and the South: comprising the South East; the South West; London

This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.

Procurement Information

Following the PIN notice and market engagement exercise, it was apparent that competition was absent and direct awards have been placed with all capable providers for each of the Lots. The PIN and market engagement documentation clearly stated that commissioners would consider placing direct awards where competition is deemed to be absent following a review of the market engagement responses.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-038737
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/030459-2023
Current Stage
Award
All Stages
Planning, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85000000 - Health and social work services

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£9,853,145 £1M-£10M

Notice Dates

Publication Date
16 Oct 20232 years ago
Submission Deadline
Not specified
Future Notice Date
12 Jan 2023Expired
Award Date
10 Mar 20232 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND - SPECIALISED COMMISSIONING
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 6LH
Post Town
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England)

Local Authority
Southwark
Electoral Ward
St George's
Westminster Constituency
Bermondsey and Old Southwark

Supplier Information

Number of Suppliers
6
Supplier Names

BIRMINGHAM WOMEN’S AND CHILDREN’S NHS FOUNDATION TRUST

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST

GUY’S AND ST THOMAS’ NHS FOUNDATION TRUST

MANCHESTER UNIVERSITY NHS FOUNDATION TRUST

OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-038737-2023-10-16T14:06:30+01:00",
    "date": "2023-10-16T14:06:30+01:00",
    "ocid": "ocds-h6vhtk-038737",
    "description": "Patients and their family/carers will have the option to choose which MS Hub Lead Centre they wish to be referred to in discussion with their referring clinician, although it is envisaged that patient flows will be mainly geographic, with patients attending the Hub Lead Centre for their Regional area. The existing contracts are due to expire on 31st March 2023 and the Commissioner is running this market engagement exercise to ascertain whether there is competition in the market and to help inform future commissioning plans. Each year in UK, there are likely to be 78 new paediatric patients who need detailed assessment and treatment in the highly specialised service. These are individuals who present with recurrent demyelination and immediately fulfil the criteria for MS or who are at risk of being diagnosed with paediatric MS within the first 12 months after presentation or who have relapsing demyelination/other acquired demyelinating syndromes. The mean age of presentation is 12 years of age. There is understood to be a current caseload of some 230 paediatric patients in England who have been diagnosed with MS, or with an 'MS-like' recurrent acquired demyelinating condition that requires the same treatment. As well as the caseload of more complex patients, at any point in time, there will be other patients being assessed, most of whom will not remain on the caseload once assessment has been completed and any care planning for local delivery has been completed. This is due to these individuals having a low level of care need or because MS or an 'MS-like' condition has been ruled out. Incumbent providers are required to respond to this market engagement exercise along with prospective providers. Contract value and activity levels have been derived based on past experience. The estimated total value of the contracts for all three Lots is PS2,550,000 and payment will be either the standard national tariffs or existing local tariffs as is currently the case. There is anticipated to be no net change in the number of patients accessing care in the NHS or the related cost. NHS England highly specialised commissioning is the contracting and commissioning authority for this service and wishes to commission centres across three Lots in England (North, Midlands and London and the South) to be delivered as part of a network arrangement as detailed in the questionnaire.",
    "initiationType": "tender",
    "tender": {
        "id": "62208 - Multiple Sclerosis",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Provision of Multiple Sclerosis Management Service for Children",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85000000",
            "description": "Health and social work services"
        },
        "mainProcurementCategory": "services",
        "description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.",
        "lots": [
            {
                "id": "1",
                "title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
                "description": "This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Technical",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": false
            },
            {
                "id": "2",
                "title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
                "description": "This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Technical",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": false
            },
            {
                "id": "3",
                "title": "Lot 3 - London and the South: comprising the South East; the South West; London",
                "description": "This exercise is to commission a service that is able to expertly manage the provision of the Multiple Sclerosis Management Service for Children, including patients with suspected Multiple Sclerosis (MS) or equally rare 'MS-like', recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which would require a similar treatment approach, including: Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination; Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and other forms of recurrent relapsing demyelination. The MS Hub Lead Centres will be geographically spaced across the Regional areas of NHS England as follows: i) Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West, ii) Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England iii) Lot 3 - London and the South: comprising the South East; the South West; London We would like to hear from incumbent and potential paediatric providers who can meet the following essential criteria: I. Have staff in place with paediatric neuroinflammatory expertise as listed in the service specification : (https://www.england.nhs.uk/wp-content/uploads/2017/08/multiple-sclerosis-mgt-for-children-sept-2017.pdf); II. Be currently actively managing, as an expert care provider and have seen face to face in the last year, a minimum of 20 children with paediatric Remitting Demyelinating Syndromes (RDS) (including first presentation or first event MS or high risk RDS); III. Be actively prescribing innovative therapeutic pharmacological MS treatments for these children using the NHS England BluTeq online system; IV. Have received in a tertiary capacity for expert review, five to ten new paediatric referrals of acute multiple sclerosis/MS-like cases per year in each of the last three years (2018/19, 2019/20 and 2020/21. With the requests being for second opinions/advice on the treatment plan. V. Must be an existing provider of tertiary paediatric neurosciences. The anticipated contract period is 3 years. The Commissioner reserves the right to direct award where competition is absent. This notice is to advise incumbent and prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach, Applications may be made jointly where partners can demonstrate appropriate expertise and meet the service criteria set out in the questionnaire and service specification: multiple-sclerosis-mgt-for-children-sept-2017.pdf (england.nhs.uk).. The questionnaire is available through the EU Supply portal: https://uk.eu-supply.com/login.asp?B=agcsu The reference is 62208 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 20th December 2022.",
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Technical",
                            "type": "cost",
                            "description": "100"
                        }
                    ]
                },
                "hasOptions": false
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85000000",
                        "description": "Health and social work services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKE"
                    },
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKC"
                    },
                    {
                        "region": "UKE"
                    },
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKC"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85000000",
                        "description": "Health and social work services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKG"
                    },
                    {
                        "region": "UKF"
                    },
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKG"
                    },
                    {
                        "region": "UKF"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85000000",
                        "description": "Health and social work services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKK"
                    },
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKI"
                    },
                    {
                        "region": "UKK"
                    },
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKI"
                    }
                ],
                "relatedLot": "3"
            }
        ],
        "communication": {
            "futureNoticeDate": "2023-01-12T00:00:00Z"
        },
        "coveredBy": [
            "GPA"
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "Following the PIN notice and market engagement exercise, it was apparent that competition was absent and direct awards have been placed with all capable providers for each of the Lots. The PIN and market engagement documentation clearly stated that commissioners would consider placing direct awards where competition is deemed to be absent following a review of the market engagement responses."
    },
    "parties": [
        {
            "id": "GB-FTS-4052",
            "name": "NHS England - Specialised Commissioning",
            "identifier": {
                "legalName": "NHS England - Specialised Commissioning",
                "id": "na"
            },
            "address": {
                "streetAddress": "80 London Road",
                "locality": "London",
                "region": "UK",
                "postalCode": "SE1 6LH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Josselin Canevet",
                "telephone": "+44 1234567890",
                "email": "josselin.canevet@nhs.net",
                "url": "https://uk.eu-supply.com/ctm/Supplier/Documents/Folder/52947"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.england.nhs.uk",
                "buyerProfile": "https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/68205",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-18796",
            "name": "Manchester University NHS Foundation Trust",
            "identifier": {
                "legalName": "Manchester University NHS Foundation Trust"
            },
            "address": {
                "locality": "Manchester",
                "region": "UKD",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-1009",
            "name": "Birmingham Women's and Children's NHS Foundation Trust",
            "identifier": {
                "legalName": "Birmingham Women's and Children's NHS Foundation Trust"
            },
            "address": {
                "locality": "Birmingham",
                "region": "UKG",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-95413",
            "name": "Great Ormond Street Hospital for Children NHS Foundation Trust",
            "identifier": {
                "legalName": "Great Ormond Street Hospital for Children NHS Foundation Trust"
            },
            "address": {
                "locality": "London",
                "region": "UKI",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-6625",
            "name": "Cambridge University Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Cambridge University Hospitals NHS Foundation Trust"
            },
            "address": {
                "locality": "Cambridge",
                "region": "UKH",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-21063",
            "name": "Guy's and St Thomas' NHS Foundation Trust",
            "identifier": {
                "legalName": "Guy's and St Thomas' NHS Foundation Trust"
            },
            "address": {
                "locality": "London",
                "region": "UKI",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-122",
            "name": "Oxford University Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Oxford University Hospitals NHS Foundation Trust"
            },
            "address": {
                "locality": "Oxford",
                "region": "UKI",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-2639",
            "name": "Arden & GEM Commissioning Support Unit",
            "identifier": {
                "legalName": "Arden & GEM Commissioning Support Unit"
            },
            "address": {
                "locality": "Derby",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody",
                "mediationBody",
                "reviewContactPoint"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-4052",
        "name": "NHS England - Specialised Commissioning"
    },
    "language": "en",
    "awards": [
        {
            "id": "030459-2023-1-1",
            "relatedLots": [
                "1"
            ],
            "title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-18796",
                    "name": "Manchester University NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "030459-2023-2-2",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-1009",
                    "name": "Birmingham Women's and Children's NHS Foundation Trust"
                },
                {
                    "id": "GB-FTS-6625",
                    "name": "Cambridge University Hospitals NHS Foundation Trust"
                }
            ]
        },
        {
            "id": "030459-2023-3-3",
            "relatedLots": [
                "3"
            ],
            "title": "Lot 3 - London and the South: comprising the South East; the South West; London",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-95413",
                    "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
                },
                {
                    "id": "GB-FTS-21063",
                    "name": "Guy's and St Thomas' NHS Foundation Trust"
                },
                {
                    "id": "GB-FTS-122",
                    "name": "Oxford University Hospitals NHS Foundation Trust"
                }
            ]
        }
    ],
    "contracts": [
        {
            "id": "030459-2023-1-1",
            "awardID": "030459-2023-1-1",
            "title": "Lot 1 - North comprising the NHS England Regions: the North East and Yorkshire; the North West,",
            "status": "active",
            "value": {
                "amount": 2797834,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-10T00:00:00Z"
        },
        {
            "id": "030459-2023-2-2",
            "awardID": "030459-2023-2-2",
            "title": "Lot 2 - the Midlands comprising the NHS England Regions: the Midlands; the East of England",
            "status": "active",
            "value": {
                "amount": 1480332,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-10T00:00:00Z"
        },
        {
            "id": "030459-2023-3-3",
            "awardID": "030459-2023-3-3",
            "title": "Lot 3 - London and the South: comprising the South East; the South West; London",
            "status": "active",
            "value": {
                "amount": 5574979,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-10T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "2",
                "measure": "bids",
                "relatedLot": "2",
                "value": 2
            },
            {
                "id": "3",
                "measure": "bids",
                "relatedLot": "3",
                "value": 4
            }
        ]
    }
}